GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals AstraZeneca
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Trials & Approvals Stroke
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Trials & Approvals Cancer
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Trials & Approvals Hemophilia A
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
Trials & Approvals Oncology Drug
ODAC Votes Against Oncopeptides’ and Spectrum’s New Oncology Drugs
2022-09-26
Trials & Approvals AstraZeneca
AstraZeneca’s Rare Disease Treatment Wins Third Approval in European Union
2022-09-23
Trials & Approvals Hypercholesterolemia
AstraZeneca Blocks Ionis’ Hypercholesterolemia Treatment from Moving into a Phase 3 Study
2022-09-23
Trials & Approvals Novo Nordisk
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Trials & Approvals Hearing Loss
Fennec’s PEDMARK Finally Gains FDA Approval to Treat Chemo-Induced Hearing Loss
2022-09-22
Trials & Approvals BridgeBio Pharma
BridgeBio and Sentynl Therapeutics’ Nulibry Gets Greenlighted In Europe
2022-09-21
Trials & Approvals Avrobio
AVROBIO’s First-of-its-Kind Gene Therapy Receives Rare Pediatric Disease Designation
2022-09-21
Trials & Approvals COVID-19
AstraZeneca’s Treatment for COVID-19 Wins European Approval
2022-09-20
Trials & Approvals HIV
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Trials & Approvals Lupus Nephritis
Aurinia Wins Approval For Lupus Nephritis Therapy In Europe
2022-09-20
1 2 3 … 39
LATEST
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Pfizer, Sangamo Re-Opens Enrolment For Hemophilia A Gene Therapy
2022-09-26
READ MORE
EVENT
2022-10-12
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2022
Japan
2022-10-26
Brussels, Belgium – EFIB 2022
Brussels, Belgium
2022-11-07
2nd World Congress on Primary Healthcare and Medicare Summit
Paris, France
2022-11-07
BioFuture | Beyond Disruption: The New Age of Healthcare and Technology
New York city
2022-11-14
MEDICA2022
Germany
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, Louisiana
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!